Search results for: France
Filter search results
OHE at the 2019 Spanish Health Economics Association (AES) Conference
5 June 2019
…result is of the highest importance; responses from the UK, France, Spain, and Italy showed convenience as the most important attribute. Confidence and convenience were jointly favoured by respondents in…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…(Netherlands, Norway and Poland), a single price ‘weighted’ by the value of each indication (Germany, France, Belgium and Austria) or individual prices for each indication (Italy). De facto, only the…
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
…curves and market shares demonstrate that access to DAAs was sped up in this second stage for Germany, Spain, Italy and Portugal. For France, access was already high at this…
How Have HTA Agencies Evolved Their Methods Over Time?
29 April 2024
Share this: Download publication Priscila Radu Gayathri Kumar Patricia Cubi-Molla Martina Garau Eleanor Bell Jia Pan Ramiro Gilardino Julie Van Bavel Agnes Brandtmüller Katherine Nelson Melinda Goodall The many changes…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
1 September 2019
Antimicrobial resistance (AMR) is a growing public health threat, limiting the ability of health care systems to prevent and treat infections and save lives. In parallel, global antibiotic development pipelines…
Indication-Based Pricing (IBP) Consultation Report
1 April 2020
Although the science underlying drug development has evolved, there has been little change in how we pay for them. As more and more medicines come to market with multiple indications…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
8 January 2020
Histology independent therapies, a new class of medicines that target cancer based on specific genomic or molecular alterations of cancer cells rather than tissue of origin, face significant methodological and…